BERLIN-CHEMIE AG
🇧🇬Bulgaria
Clinical Trials
9
Active:7
Completed:2
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
13
NMPA:12
EMA:1
Drug Approvals
Dapoxetine Hydrochloride Tablet
- Product Name
- 必利劲
- Approval Number
- 国药准字HJ20150564
- Approval Date
- May 31, 2024
NMPA
Dapoxetine Hydrochloride Tablet
- Product Name
- 必利劲
- Approval Number
- 国药准字HJ20150563
- Approval Date
- May 31, 2024
NMPA
Levothyroxine Sodium Tablets
- Product Name
- 雷替斯
- Approval Number
- 国药准字HJ20160236
- Approval Date
- Dec 1, 2020
NMPA
Levothyroxine Sodium Tablets
- Product Name
- 雷替斯
- Approval Number
- 国药准字HJ20160235
- Approval Date
- Dec 1, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)No trials found
News
No news found